Childress Capital Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Childress Capital Advisors's NVS Position: Q2 2026 in Review
Childress Capital Advisors increased its Novartis (NVS) stake by 0.72% in Q2 2026, buying an estimated $1.65K and bringing the position to 1,547 shares worth $242K. The position accounts for 0.04% of the portfolio, ranked #327.
Childress Capital Advisors first reported a position in NVS in Q4 2020 and has held it in 4 quarters since. 1,621 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Childress Capital Advisors held 1,547 shares of Novartis worth $242K as of Q2 2026.
- Childress Capital Advisors bought 11 Novartis shares in Q2 2026, an estimated $1.65K.
- Novartis made up 0.04% of Childress Capital Advisors's portfolio in Q2 2026, its #327 holding.
- Childress Capital Advisors first reported a position in Novartis in Q4 2020 and has held it in 4 quarters since.
- 1,621 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Childress Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.